EP3429571
COMBINATIONS OF LSD1 INHIBITORS FOR USE IN THE TREATMENT OF NEOPLASTIC DISEASES
:
EP einkaleyfi: EP einkaleyfi tilnefnt til gildistöku á Íslandi:
13.3.2017:
8.10.2025:
17710261.3
:
12.3.2037:
12.3.2026
:
COMBINATIONS OF LSD1 INHIBITORS FOR USE IN THE TREATMENT OF NEOPLASTIC DISEASES
13.3.2017
8.10.2025
12.3.2026
:
Oryzon Genomics, S.A.:
Carrera de San Jérónimo 15 2nd floor, 28014 Madrid, ES
:
DEMARIO, Mark:
New York NY 10016, US
:
PIERCEALL, William:
New York NY 10016, US
:
MACK, Fiona:
New York NY 10016, US
:
MAES, Tamara:
08940 Cornellà de Llobregat, ES
:
LUNARDI, Serena:
08940 Cornellà de Llobregat, ES
:
201662308529 P:
15.3.2016:
US
:
EP2017055784:
13.3.2017
:
A61K 31/4745, A61K 31/12, A61P 35/00, A61K 31/7068, A61K 31/704, A61K 31/555, A61K 31/519, A61K 31/495, A61K 31/475, A61K 31/4045, A61K 31/337, A61K 31/282, A61K 31/19, A61K 31/135, A61K 31/167, A61K 31/404, A61K 31/4545, A61K 31/52, A61K 31/496, A61P 35/02